How the biobank.cy Center of Excellence is advancing personalised medicine

As it shifts from early-stage innovation to mass-market integration, the alternative protein sector faces critical hurdles, including complex technical production issues and shifting regulatory and consumer landscapes

Research and scale-up funding could yield massive alternative protein food market 

The Rare Disease Moonshot explains why rare disease innovation will enrich the EU’s life sciences sector